Floreo
Floreo develops FDA-designated virtual reality therapy software that delivers immersive social, communication, and behavioral skills training to neurodiverse individuals (autism, ADHD, anxiety), serving healthcare providers, K-12 schools, state disability agencies, and families via subscription, Medicaid waiver, and CPT III billing.
- Company typePrivate
- Founded2016
- HeadquartersWashington, United States
- Headcount11–50
- GTM typeB2B and B2C
- OfferingSoftware
What Floreo does
Floreo is a privately held, Delaware-incorporated virtual reality behavioral therapy company founded in 2016 by Vijay Ravindran and headquartered in Chevy Chase, Maryland. It develops research-based VR simulations that allow neurodiverse individuals — primarily those with Autism Spectrum Disorder, ADHD, and anxiety — to practice social, communication, behavioral regulation, daily living, and job skills in safe, repeatable virtual environments. The platform supports Meta Quest 2/3/Pro, PICO enterprise headsets, and a smartphone/Google Cardboard browser mode, with telehealth-ready remote delivery. Its clinical content is built by an in-house team of BCBAs, a CCC-SLP with 30+ years of experience, and an MD clinical consultant specializing in neurodevelopmental disabilities.
The product portfolio centers on the Floreo VR Platform with audience-specific modules for Providers, Education, and Families. FloreoRx is the company's FDA-regulated therapeutic software product, supported by a 125-patient pivotal trial across 18 Cortica Healthcare sites demonstrating a 45.6% responder rate versus 23.3% in a VR control group, 95.1% skill mastery, and sustained improvements at 60-day follow-up; a De Novo FDA request was submitted in April 2026 following Breakthrough Device designation and TAP Program acceptance in December 2023. The portfolio was expanded in April 2024 with the acquisition of Autism Eyes (a Cleveland Clinic Innovations portfolio company in autism diagnostics), and in October 2025 with the Digital Boundaries online-safety simulation series developed with the Cuyahoga County Board of Developmental Disabilities. The platform integrates generative AI characters powered by OpenAI for conversational practice.
Floreo monetizes via subscription licensing to families, schools, and enterprise providers; state Medicaid waiver reimbursement in Wisconsin, Tennessee, New York, Maryland, and Washington DC; bundled VR headset equipment rental; direct enterprise and government contracts (e.g., Tennessee DIDD two-year pilot); and CPT III Code 0770T for clinical VR therapy billing. Distribution runs through direct enterprise sales, the floreovr.com storefront, the Meta Quest Store, and the PICO Business Store. To date, Floreo has raised approximately $12.1M in venture funding across a 2017 seed, an October 2022 $10M Series A led by Tenfore Holdings, and a small July 2025 round; Cleveland Clinic joined as a strategic investor and board observer in April 2024.
Floreo firmographics
Firmographics- Name
- Floreo
- Legal name
- Floreo, Inc.
- Website
- https://floreovr.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Floreo develops FDA-designated virtual reality therapy software that delivers immersive social, communication, and behavioral skills training to neurodiverse individuals (autism, ADHD, anxiety), serving healthcare providers, K-12 schools, state disability agencies, and families via subscription, Medicaid waiver, and CPT III billing.
- Ownership category
- akta.pro rank
Floreo industry classification
Industry- Product category
- Virtual Reality Behavioral Therapy Software
- NAICS
- Services for the Elderly and Persons with Disabilities (624120)
- akta.pro primary industry
- Telehealth/Remote ABA & Digital Behavior Coaching (EDAKAHAL)
Keywords
Where Floreo is headquartered
LocationHeadquarters
- HQ city
- Washington
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Floreo business model
Business model- GTM type
- B2B and B2C
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations
Revenue model
- Subscription Licensing: Recurring subscription model for access to VR lesson library and platform features. Subscriptions available for families, schools, and enterprise/organizational accounts. Pricing varies by account type and user count.
- State Waiver Reimbursement: Floreo subscriptions eligible for reimbursement through state Medicaid waiver programs including Wisconsin (Children's Long Term Support waiver), Tennessee (MAPS program), New York (OPWDD Self Directed Services Waiver), Maryland, and Washington DC. Equipment rental also covered under some waivers.
- Equipment Rental: VR headset rental bundled with subscriptions for families, particularly through state waiver programs. Provides complete solution including hardware and software.
- CPT III Code 0770T: Floreo sponsored the application for CPT III Code 0770T representing practice expense for VR technology software, enabling clinics to report VR technology use per session for therapy billing.
- Enterprise/Government Contracts: Direct contracts with state government agencies (Tennessee DIDD), county boards of developmental disabilities, and school districts for deployment of VR therapy programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Enterprise/organizational subscription for providers, schools, and institutions |
| Subscription | Annual | Floreo Classroom Bundle for schools |
| Subscription | Monthly | Family/home subscription |
| Unit Pricing | Monthly | Equipment rental with subscription |
Go-to-market motion4 records
Distribution channels6 records
Marketing channels6 records
Floreo product offering
Product offeringCore offering
Floreo provides a research-based virtual reality behavioral therapy platform that enables neurodiverse individuals (primarily those with autism, ADHD, and anxiety) to practice social, communication, behavioral regulation, daily living, and independent living skills through immersive VR simulations. The platform is offered as audience-tailored subscriptions: Floreo for Providers (clinics and therapy practices), Floreo for Education (K-12 schools and districts), and Floreo for Families (home use), with optional bundled VR headset rental and telehealth-ready remote delivery. A separate regulated product, FloreoRx, is pursuing FDA De Novo authorization as a therapeutic device for ASD social communication skills.
Product overview
Floreo is a virtual reality behavioral therapy platform consisting of a core VR software product supplemented by audience-specific modules. The core Floreo VR Platform delivers immersive social and behavioral skills training through VR simulations accessible via smartphone/Cardboard, Meta Quest, and PICO headsets. Enterprise variants include Floreo for Providers (clinics/therapists), Floreo for Education (schools), and Floreo for Families (home use). FloreoRx represents the company's FDA-regulated therapeutic device pathway targeting ASD social communication skills. The portfolio was expanded through the 2024 acquisition of Autism Eyes (autism diagnostics from Cleveland Clinic) and the Digital Boundaries content series (online safety training). The platform incorporates AI characters powered by OpenAI for interactive conversational experiences.
Differentiator
Problem solved
Functional benefit
Products and services
- Floreo for Providers Enterprise VR subscription for healthcare providers (clinics, therapy practices, ABA therapy organizations) enabling clinicians to deliver VR-based behavioral therapy sessions with progress tracking, reporting, telehealth-ready delivery, and support for CPT III Code 0770T billing.
- Floreo for Education K-12 education subscription enabling schools, charter schools, and districts to use Floreo VR lessons for social skills instruction, classroom accommodations, special education programming, executive functioning skill development, and transition planning, with FERPA-compliant school official framework.
- Floreo for Families Direct-to-consumer monthly home subscription for parents and caregivers of neurodiverse children and adults, enabling home-based VR therapy practice, skill reinforcement, and family coaching with COPPA compliance and optional Meta Quest headset rental.
- FloreoRx FDA-regulated VR-based therapeutic software (De Novo pending) designed to support skill development in individuals with Autism Spectrum Disorder; if authorized, would be one of the first FDA-authorized therapeutic devices for core social communication challenges associated with ASD.
- Digital Boundaries Series of VR simulations focused on online safety skills for neurodivergent youth and adults, developed in partnership with Cuyahoga County Board of Developmental Disabilities and designed to be rolled out across Cleveland and nationwide.
- Autism Eyes Acquired autism diagnostics product from Cleveland Clinic Innovations providing accelerated and objective assessment of autism risk to streamline diagnosis and potentially improve patient outcomes; expanded Floreo into the autism diagnostics space.
Quantifiable outcome
- 45.6% responder rate vs 23.3% VR control in pivotal trial; 95.1% skill mastery rate; sustained improvements at 60-day follow-up; no serious adverse events
Companies that use Floreo
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
Floreo technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration4 records
AI capability7 records
Feature6 records
Floreo partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Cuyahoga County Board of Developmental DisabilitiescorePartnership to create Digital Boundaries online safety training program for neurodivergent youth and adults, to be rolled out across Cleveland and nationwide.
- Cleveland Clinic Innovations / Autism EyescoreAcquired Autism Eyes, a Cleveland Clinic Innovations portfolio company focused on autism diagnostics, expanding Floreo into diagnostics space. Cleveland Clinic also made a strategic investment in Floreo and joined its board as an observer.
- PICO Business Store (ByteDance)coreFloreo available in PICO Business Store for enterprise PICO headset users (Neo3, Neo3 Pro/Pro Eye, PICO 4E, PICO 4 Ultra).
- Tennessee Department of Intellectual and Developmental DisabilitiescoreTwo-year contract for VR pilot project developing transportation and job skills curriculum for people with intellectual and developmental disabilities.
- Cortica HealthcarecoreConducted pivotal clinical trial for FloreoRx FDA submission across 18 clinical sites with 125 enrolled patients demonstrating statistically significant improvements.
- Meta (Meta Quest)coreCollaboration with Meta for Immersive Learning Program providing free Meta Quest 2 headsets to schools; Floreo available on Meta Quest store.
- Easterseals FloridaminorWorkforce development program using Floreo with neurodiverse students; Easterseals received Meta Quest headsets through Immersive Learning Program.
- The School District of Palm Beach CountyminorFlorida school district signed up to implement Floreo program for neurodiverse students.
- Wattle Supports PTY LTDminorAustralia-based partner signed up to begin Floreo program serving neurodiverse clients and community.
Scale indicators6 records
Recent moves6 records
Expansion highlights7 records
Floreo competitors and assessment
Company assessmentDirect peers
- AppliedVR: AppliedVR develops FDA-authorized VR therapeutic software (EaseVRx for chronic pain) and is expanding into mental health and behavioral indications. Like Floreo, it pursues the FDA digital therapeutics regulatory pathway and distributes via consumer VR hardware, making it a closely comparable regulatory and commercial peer.
- XRHealth: XRHealth operates a VR-based telehealth platform delivering clinician-supervised therapeutic experiences across mental health, neurological, and physical conditions. It directly parallels Floreo's VR telehealth delivery model, multi-condition content library, and provider/clinic GTM motion.
- BehaVR: BehaVR builds immersive VR therapeutics for mental health (anxiety, depression, chronic pain) and partners with payers and providers on prescription digital therapeutics. Like Floreo, it combines clinical evidence generation with multi-headset distribution and a regulatory-grade development approach.
- PresenceLearning: PresenceLearning provides live, online tele-ABA and related special education services to schools and districts nationwide. It overlaps directly with Floreo's behavioral intervention + telehealth delivery focus on the school-district and provider buyer, addressing a similar neurodiverse learner base.
Broad incumbents
- CentralReach: CentralReach is an established practice management and clinical platform serving ABA and behavioral health providers at scale. It represents the incumbent software stack that Floreo providers may already use, making it a competitor for clinician wallet share and a potential integration or competitive threat to Floreo's clinical workflow layer.
- Rethink Behavioral Health: Rethink provides digital tools, training, and consulting for ABA providers, educators, and employers serving individuals with autism and IDD. It is a broader incumbent in the same behavioral intervention space Floreo targets, with overlapping school and provider buyers.
Emerging players
- Cognivive: Cognivive develops VR-based cognitive and behavioral therapy experiences, including attention and executive function training. It is an emerging peer focused on a narrower cognitive therapy niche within the same VR-based behavioral intervention category Floreo occupies.
- Limbic: Limbic builds AI-driven mental health support tools (including AI therapy companions) used by healthcare providers. While not VR-based, its focus on AI-augmented behavioral therapy delivery for clinical populations makes it thematically comparable to Floreo's generative AI character work in VR lessons.
Others
- HopSkipDrive: HopSkipDrive is a specialized ride service for vulnerable populations including children with special needs, frequently reimbursed through Medicaid waivers in multiple states. It is a relevant peer in the special-needs Medicaid waiver ecosystem where Floreo also distributes subscriptions to families.
- Cleveland Clinic Innovations: Cleveland Clinic Innovations is the corporate venture arm of Cleveland Clinic and was a prior owner of Autism Eyes, now acquired by Floreo. Cleveland Clinic also made a strategic investment in Floreo and holds a board observer seat — making it both a transaction counterparty and a strategic backer in the neurodiverse care space Floreo operates in.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Floreo social profiles
Digital presenceFloreo compliance and trust
Trust signalCompliance4 records
Floreo financial estimates
Financial estimateRevenue estimate
Valuation estimate
Floreo leadership team
Management profileNumber of profiles
Profiles8 records
Floreo subsidiaries and ownership
Company hierarchySubsidiaries1 record
Floreo funding detail
Funding detailFunding overview
Funding rounds5 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Floreo M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Floreo
What does Floreo do?
Floreo provides a research-based virtual reality behavioral therapy platform that enables neurodiverse individuals (primarily those with autism, ADHD, and anxiety) to practice social, communication, behavioral regulation, daily living, and independent living skills through immersive VR simulations. The platform is offered as audience-tailored subscriptions: Floreo for Providers (clinics and therapy practices), Floreo for Education (K-12 schools and districts), and Floreo for Families (home use), with optional bundled VR headset rental and telehealth-ready remote delivery. A separate regulated product, FloreoRx, is pursuing FDA De Novo authorization as a therapeutic device for ASD social communication skills.
Is Floreo a public or private company?
Floreo is a private company. It is classified as venture growth investor backed and is currently operating.
When was Floreo founded?
Floreo was founded in 2016. It employs 11 to 50 people.
Where is Floreo based?
Floreo is headquartered in Washington, United States, in the North America region.
How does Floreo make money?
Five revenue lines are on record. Subscription Licensing is the primary driver. The others are state Waiver Reimbursement, equipment Rental, CPT III Code 0770T and enterprise/Government Contracts.
Who are Floreo's main competitors?
Direct peers on record are AppliedVR, XRHealth, BehaVR and PresenceLearning. Broad incumbents are CentralReach and Rethink Behavioral Health. Emerging players are Cognivive and Limbic. Others are HopSkipDrive and Cleveland Clinic Innovations.
Does Floreo have an API?
No public API is recorded for Floreo.
What industry is Floreo in?
Floreo's product category is Virtual Reality Behavioral Therapy Software. Its primary akta.pro industry code is EDAKAHAL, Telehealth/Remote ABA & Digital Behavior Coaching. Its NAICS code is 624120.